According to the SEC Form 4 filings, Szot Matthew K, being in a position of
No biography is available at this moment.
Buys | $0 | 0 | 0 |
Sells | $69,236 | 2 | 100 |
| 2025-12-29 | Sale | Cadrenal Therapeutics, Inc. Common Stock CVKD | Chief Financial Officer | 9,933 0.4502% | $6.97 | $69,233 | -37.63% | |
| 2025-11-14 | Sale | SenesTech, Inc. SNES | director | 1 <0.0001% | $2.75 | $3 | -42.43% | |
| 2025-10-27 | Sale | Cadrenal Therapeutics, Inc. Common Stock CVKD | Chief Financial Officer | 1,800 0.0893% | $13.99 | $25,182 | -60.61% | |
| 2025-10-24 | Sale | Cadrenal Therapeutics, Inc. Common Stock CVKD | Chief Financial Officer | 1,800 0.0893% | $13.99 | $25,182 | -63.34% | |
| 2025-10-13 | Sale | Cadrenal Therapeutics, Inc. Common Stock CVKD | Chief Financial Officer | 1,800 0.0884% | $14.07 | $25,326 | -61.9% | |
| 2025-10-09 | Sale | Cadrenal Therapeutics, Inc. Common Stock CVKD | Chief Financial Officer | 1,693 0.0815% | $13.99 | $23,685 | -62.09% | |
| 2025-10-06 | Sale | Cadrenal Therapeutics, Inc. Common Stock CVKD | Chief Financial Officer | 107 0.0054% | $13.99 | $1,497 | -59.35% | |
| 2025-10-01 | Sale | Cadrenal Therapeutics, Inc. Common Stock CVKD | Chief Financial Officer | 1,700 0.084% | $13.99 | $23,783 | -60.67% | |
| 2025-09-29 | Sale | Cadrenal Therapeutics, Inc. Common Stock CVKD | Chief Financial Officer | 100 0.0051% | $14.00 | $1,400 | -58.35% | |
| 2025-09-25 | Sale | Cadrenal Therapeutics, Inc. Common Stock CVKD | Chief Financial Officer | 10,900 0.5431% | $14.05 | $153,182 | -59.86% | |
| 2025-09-24 | Sale | Cadrenal Therapeutics, Inc. Common Stock CVKD | Chief Financial Officer | 1,500 0.0744% | $14.00 | $20,993 | -58.64% | |
| 2025-08-28 | Sale | Cadrenal Therapeutics, Inc. Common Stock CVKD | Chief Financial Officer | 400 0.0206% | $14.00 | $5,600 | -49.74% | |
| 2025-08-27 | Sale | Cadrenal Therapeutics, Inc. Common Stock CVKD | Chief Financial Officer | 1,600 0.0785% | $13.99 | $22,392 | -51.83% |